Effects of M1selective antimuscarinics on respiratory chemosensitivity in humans

Respiration Physiology

Volumn 103, Issue 2, 1996, Pages 127-135

  Akiyama, Yasushi ^a   Nishimura, Masaharu ^a   Kobayashi, Shuichi ^a   Yamamoto, Makoto ^a   Miyamoto, Kenji ^a   Kawakami, Yoshikazu ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Control of breathing, ventilatory response; Hypercapnia, ventilatory response; Hypoxia, ventilatory response; Mammals, humans; Pharmacological agents, M1 antagonists; Ventilation, hypercapnic, hypoxic response

Indexed keywords

BIPERIDEN; BIPERIDEN LACTATE; DRUG DERIVATIVE; MUSCARINIC RECEPTOR BLOCKING AGENT; PIRENZEPINE; MUSCARINIC M1 RECEPTOR; PLACEBO;

ADOLESCENT; ADULT; ARTICLE; BREATHING; CHEMORECEPTOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; DOUBLE BLIND PROCEDURE; HUMAN EXPERIMENT; HYPERCAPNIA; HYPOXIA; INTRAVENOUS DRUG ADMINISTRATION; NORMAL HUMAN; PRIORITY JOURNAL; RESPIRATION CONTROL;

ADOLESCENT; ADULT; BIPERIDEN; CHEMORECEPTORS; HUMANS; MALE; MUSCARINIC ANTAGONISTS; PIRENZEPINE; RESPIRATION;

EID: 0029670251     PISSN: 00345687     EISSN: None     Source Type: Journal    
DOI: 10.1016/0034-5687(95)00088-7     Document Type: Article

References (25)

1. Akiyama, Y., M. Nishimura, A. Suzuki, M. Yamamoto, F. Kishi and Y. Kawakami (1990). Naloxone increases ventilatory response to hypercapnic hypoxia in healthy adult humans. Am. Rev. Respir. Dis. 142: 301-305.
2. Burton, M.D., D.C. Johnson and H. Kazemi (1989). CSF acidosis augments ventilation through cholinergic mechanisms. J. Appl. Physiol. 66: 2565-2572.
3. Carmine, A.A. and R.N. Brogden (1985). Pirenzepine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer disease and other allied diseases. Drugs 30: 85-126.
4. Cazzola, M., M.G. Matera, G. D'Amato, D. De Santis, S. Maione, M. Lisa, M.L. Cenicola and E. Marmo (1989). Evidence of muscarinic receptor subtypes in airway smooth muscle of normal volunteers and of chronic obstructive pulmonary disease patients. Int. J. Clin. Pharm. Res. 9: 65-70.
5. Collins, D.D., C.H. Scoggin, C.W. Zwillich and J.V. Weil (1978). Hereditary aspects of decreased hypoxic response. J. Clin. Invest. 62: 105-110.
6. Dev, N.B. and H.H. Loeschcke (1979). A cholinergic mechanism involved in the respiratory chemosensitivity of the medulla oblongata in the cat. Pflügers Arch. 379: 29-36.
7. Dinger, B.G., T. Hirano and S.J. Fidone (1986). Autoradiographic localization of muscarinic receptors in rabbit carotid body. Brain Res. 367: 328-331.
8. Ehlert, F.J. and L.L.P. Tran (1990). Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain. J. Pharmacol. Exp. Ther. 255: 1148-1157.
9. Fitzgerald, R.S. and M. Shirahata (1994). Acetylcholine and carotid body excitation during hypoxia in cats. J. Appl. Physiol. 76: 1566-1574.
10. + in the respiratory chemosensitive structures of the ventral medulla oblongata of rats in vitro. Pflügers Arch. 379: 125-135.
11. Gesell, R. and E.T. Hansen (1943). Eserine, acetylcholine, atropine and nervous integration. Am. J. Physiol. 139: 371-385.
12. Grimaldi, R., E. Perucca, G. Ruberto, C. Gelmi, F. Trimarchi, M. Hollmann and A. Crema (1986). Pharmacokinetic and pharmacodynamic studies following the intravenous and oral administration of the antiparkinsonian drug biperiden to normal subjects. Eur. J. Clin. Pharmacol. 29: 735-737.
13. Hosey, M.M. (1992). Diversity of structure, signaling and regulation within the family of muscarinic cholinergic receptors. FASEB J. 6: 845-852.
14. Kawakami, Y., T. Yoshikawa, Y. Asanuma and M. Murao (1981). A control system for arterial blood gases. J. Appl. Physiol. 50: 1362-1366.
15. Kawakami, Y., T. Yoshikawa, A. Shida, Y. Asanuma and M. Murao (1982). Control of breathing in young twins. J. Appl. Physiol. 52: 537-542.
16. Lydic, R., H.A. Baghdoyan, R. Wertz and D.P. White (1991). Cholinergic reticular mechanisms influence state-dependent ventilatory response to hypercapnia. Am. J. Physiol. 261: R738-R746.
17. Nattie, E.E., J. Wood, A. Mega and W. Goritski (1989). Rostral ventrolateral medulla muscarinic receptor involvement in central ventilatory chemosensitivity. J. Appl. Physiol. 66: 1462-1470.
18. Nattie, E.E. and A. Li (1990). Ventral medulla sites of muscarinic receptor subtypes involved in cardiorespiratory control. J. Appl. Physiol. 69: 33-41.
19. Severinghaus, J.W. and M. Stupfel (1955). Respiratory dead space increase following atropine in man, and atropine, vagal or ganglionic blockade and hypothermia in dogs. J. Appl. Physiol. 8: 81-87.
20. Shaw, K., W. Montague and D.J. Pallot (1989). Biochemical studies on the release of catecholamines from the rat carotid body in vitro. Biochim. Biophys. Acta 1013: 42-46.
21. Smith, T.C., G.W. Stephen, L. Zeiger and H. Wollman (1967). Effects of premedicant drugs on respiration and gas exchange in man. Anesthesiology 28: 883-890.
22. Syvälahti, E.K.G., L. Laurén, J. Markkanen and R. Kunelius (1987). Interaction of psychotropic drugs with brain muscarinic cholinoceptors: similarities of biperiden with pirenzepine in receptor binding properties. Pharmacol. Toxicol. 60: 66-69.
23. Vizek, M., C.K. Pickett and J.V. Weil (1987). Interindividual variation in hypoxic ventilatory response: potential role of carotid body. J. Appl. Physiol. 63: 1884-1889.
24. Williams, G.W., S.B. Forsythe, S.C. Textor and R.C. Tarazi (1984). Analysis of relative change and initial value in biological studies. Am. J. Physiol. 246: R122-R126.
25. Yokogawa, K., E. Nakashima, J. Ishizaki, M. Hasegawa, H. Kido and F. Ichimura (1992). Brain regional pharmacokinetics of biperiden in rats. Biopharm. Drug Dispos. 13: 131-140.